Structural Study of SARS-CoV-2 Antibodies Identifies a Broad-Spectrum Antibody That Neutralizes the Omicron Variant by Disassembling the Spike Trimer

Wuqiang Zhan,Xiaolong Tian,Xiang Zhang,Shenghui Xing,Wenping Song,Qianying Liu,Aihua Hao,Yuxia Hu,Meng Zhang,Tianlei Ying,Zhenguo Chen,Fei Lan,Lei Sun
DOI: https://doi.org/10.1128/jvi.00480-22
IF: 6.549
2022-08-05
Journal of Virology
Abstract:The emergence of the Omicron strain of SARS-CoV-2 caused higher immune escape, raising unprecedented concerns about the effectiveness of antibody therapies and vaccines. In this study, we identified a SARS-CoV-2 neutralizing antibody, 553-49, which neutralizes all variants by targeting a completely conserved novel epitope.
virology
What problem does this paper attempt to address?
The problem that this paper attempts to solve is the immune evasion problem brought about by the continuous emergence of new variants of the SARS - CoV - 2, especially the Omicron variant. Specifically, the research aims to develop a neutralizing antibody that can recognize conserved and widely - existing epitopes to address the impact of emerging SARS - CoV - 2 variants on the effectiveness of existing antibody therapies and vaccines. ### Research Background and Problems 1. **Challenges of SARS - CoV - 2 Variants**: As the SARS - CoV - 2 spreads among humans, multiple variants (such as Alpha, Beta, Gamma, Delta, and Omicron) have emerged, which bring a higher risk of immune evasion and have raised global concerns. 2. **Effectiveness of Antibody Therapies**: The neutralizing ability of existing neutralizing antibodies (NAbs) against certain variants (such as Omicron) has significantly decreased. Therefore, there is an urgent need to develop new antibodies that can effectively neutralize all variants. 3. **Selection of Target Epitopes**: In order to improve the broad - spectrum and durability of antibodies, researchers are committed to finding and validating those highly conserved epitopes in different variants, so as to develop more effective therapeutic antibodies. ### Main Findings of the Research 1. **Broad - Spectrum Neutralizing Activity of 553 - 49 Antibody**: The research has discovered a neutralizing antibody named IgG 553 - 49, which can neutralize the Omicron variant by targeting a completely new conserved epitope, and this epitope has remained highly conserved during virus evolution. 2. **Mechanism Revealed by Structural Analysis**: Through cryo - EM technology, researchers have analyzed the structure of the 553 - 49 and Omicron S - protein complex, revealing the unique mechanism by which 553 - 49 neutralizes the virus by disassembling the S trimer. 3. **Mechanisms of Other Antibodies**: - IgG 553 - 15 forms a dimer by cross - linking two S trimers, resulting in steric hindrance and virus particle aggregation, thereby neutralizing the virus. - IgG 553 - 60 neutralizes the virus by preventing the receptor - binding domain (RBD) from binding to the ACE2 receptor. ### Conclusions and Significance This research not only provides new ideas for developing broad - spectrum neutralizing antibodies against Omicron and other future variants but also reveals the diversity of the mechanisms of different antibodies. In particular, the highly conserved epitope targeted by the 553 - 49 antibody is expected to become an important target for future anti - SARS - CoV - 2 drug development. ### Key Formulas and Structure Display - **Epitope Coverage Area**: The surface area buried when IgG 553 - 49 binds to RBD is \(1,076 \, Å^2\). - **Number of Hydrogen Bonds**: The interaction between 553 - 15 Fab and RBD involves a surface area of 787 \(Å^2\), which contains multiple hydrogen bonds. These findings are of great significance for understanding the immune evasion mechanism of SARS - CoV - 2 and developing more effective antibody therapies.